VERTEX PHARMACEUTICALS INC (VRTX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for VRTX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VRTX | Co-Founder and CEO, Homeward Health Inc.; Co-Founder and Chief Executive Officer | 51 | ["Co-Founder and Chief Executive Officer of Homeward Health Inc. since 2022", "President of Livongo Health from December 2018 to October 2020", "Chief Medical Officer of Livongo Health from September 2015 to December 2018", "Served in multiple leadership roles at Castlight Health, Inc. from 2010 to 2015", "Member of the board of directors at Revolution Healthcare Acquisition Corp. from March 2021 to December 2022", "Member of the board of directors at Health Assurance Acquisition Corp. until November 2022", "Holds a B.S. in Biology, an M.D. from Johns Hopkins, and an M.S. in Health Services Research from Stanford"] | ["Management Development and Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age: 51 Director Since: 2024 Board Committees: Member Management Development and Compensation Committee Experience: Other Public Company Boards: None Co-Founder and Chief Executive Officer of Homeward Health Inc., a company committed to rearchitecting the delivery of health and care in rural America in partnership with communities, since 2022 President of Livongo Health, a biotechnology company, from December 2018 to October 2020, and served as the Chief Medical Officer from September 2015 to December 2018 Served in multiple leadership roles at Castlight Health, Inc., a healthcare navigation company, from 2010 to 2015, most recently as Chief Medical Officer Member of the board of directors at Revolution Healthcare Acquisition Corp., a special purpose acquisition company, from March 2021 to December 2022 Member of the board of directors at Health Assurance Acquisition Corp., a special purpose acquisition company, from September 2020 until it liquidated in November 2022 Holds a B.S. in Biology from the College of the Holy Cross, an M.D. from Johns Hopkins School of Medicine, and an M.S. in Health Services Research from Stanford University Key Skills and Qualifications: Dr. Schneider has deep knowledge and expertise in healthcare and technology. She has led or held senior leadership roles in multiple companies focused on delivering innovative solutions in healthcare management. At Livongo, Dr. Schneider led the company through the largest consumer digital health initial public offering in history as well as its merger with Teladoc Health, the industry s largest ever merger. Dr. Schneider brings extensive experience as a practicing physician and as a leader building healthcare companies that use technology to provide access to clinical services.